Villy Valcheva
Hoofd Techniek/Wetenschap/O&O bij GH RESEARCH PLC
Actieve functies van Villy Valcheva
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GH RESEARCH PLC | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Villy Valcheva
Eerdere bekende functies van Villy Valcheva
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | - | - |
Opleiding van Villy Valcheva
| Medical University of Plovdiv | Doctorate Degree |
| Trinity College Dublin | Graduate Degree |
Statistieken
Internationaal
| Ierland | 3 |
| Verenigde Staten | 2 |
| Bulgarije | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GH RESEARCH PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Villy Valcheva
- Ervaring
